Thymidylate synthase (TS) genotype-directed phase II trial of oral capecitabine for 2-line treatment of advanced pancreatic cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Mar 2010 Biomarkers information updated
- 16 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.